New Guidelines on Men with Erectile Dysfunction and Cardiac Health Published in the Journal of Sexual Medicine Concludes PDE-5 Inhibitors are Still Safe for the Cardiovascular System
Their summary and guidelines have now been published in the Journal of Sexual Medicine.
- Their summary and guidelines have now been published in the Journal of Sexual Medicine.
- They determined that PDE-5 inhibitors are still safe for the cardiovascular system.
- The conference was funded by an unrestricted grant from Sanofi to readdress the cardiovascular workup of men presenting with ED and the cardiovascular safety of the phosphodiesterase-5 (PDE-5) inhibitors for treating ED.
- Patients with ED should be characterized as low-risk, intermediate (or indeterminable), or high-risk of developing a cardiac event with sexual activity.